Lensar, Alcon still working on US FTC second request, aim to close before July
( February 25, 2026, 22:47 GMT | Official Statement) -- MLex summary: Lensar, a medical technology company working on robotic laser treatments for the treatment of cataracts, told the US Securities and Exchange Commission that it's continuing to cooperate with the US Federal Trade Commission on its second request related to its acquisition by Alcon Research. Lensar expects the merger to close in the first half of 2026. Statement follows in full. ...
Prepare for tomorrow’s regulatory change, today
MLex identifies risk to business wherever it emerges, with specialist reporters across the globe providing exclusive news and deep-dive analysis on the proposals, probes, enforcement actions and rulings that matter to your organization and clients, now and in the longer term.
Know what others in the room don’t, with features including:
- Daily newsletters for Antitrust, M&A, Trade, Data Privacy & Security, Technology, AI and more
- Custom alerts on specific filters including geographies, industries, topics and companies to suit your practice needs
- Predictive analysis from expert journalists across North America, the UK and Europe, Latin America and Asia-Pacific
- Curated case files bringing together news, analysis and source documents in a single timeline
Experience MLex today with a 14-day free trial.